Stradling Yocca advises Vessix in $425 million sale to Boston Scientific
Stradling Yocca Carlson & Rauth PC provided counsel to Laguna Hills-based medical device developer Vessix Vascular Inc. in its $425 million sale to Boston Scientific Corp.
Newport Beach-based shareholder Shivbir S. Grewal led the Stradling team, which included shareholders Timothy F. O'Brien and Benedict Kwon and associates...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In